Altamira Therapeutics CYTOF
OTC CYTOF
$0.07 +0.00 (+0.00%)
At close: Nov 13, 2026 · 4:00 PM EST

Altamira Therapeutics (CYTOF) EBIT (2013 - 2018)

Updated

Altamira Therapeutics (CYTOF) recorded EBIT of -$7.33 million in FY2019, compared with -$11.01 million in FY2018.

Analysis

Altamira Therapeutics (CYTOF) EBIT (2013 - 2018) Analysis & Trends

Starting with FY2015, Altamira Therapeutics' EBIT history includes 5 years.

  • The FY2019 figure is the highest annual EBIT in data going back to FY2015.
  • Per Business Quant data, CYTOF's EBIT was -$11.01 million in FY2018, -$24.75 million in FY2017, -$30.69 million in FY2016 and -$32.11 million in FY2015.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2018 -673,030.30
Sep 30, 2018 -2.91 Mn
Jun 30, 2018 -3.16 Mn
Mar 31, 2018 -4.54 Mn
Dec 31, 2017 -5.51 Mn
Sep 30, 2017 -5.78 Mn
Jun 30, 2017 -6.05 Mn
Mar 31, 2017 -7.38 Mn
Dec 31, 2016 -6.32 Mn
Sep 30, 2016 -7.73 Mn
Jun 30, 2016 -9.28 Mn
Mar 31, 2016 -7.41 Mn
Dec 31, 2015 -6.85 Mn
Sep 30, 2015 -7.48 Mn
Jun 30, 2015 -10.33 Mn
Mar 31, 2015 -7.52 Mn
Dec 31, 2014 -5.82 Mn
Sep 30, 2014 -6.23 Mn
Jun 30, 2014 -5.68 Mn
Mar 31, 2014 -6.56 Mn
API Access

Altamira Therapeutics EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit&ticker=CYTOF&period=max&api_key=YOUR_API_KEY